Abbott Laboratories vs Edwards Lifesciences
Abbott Laboratories (ABT) and Edwards Lifesciences (EW) side by side: how big they are, what they earn, how their shares have moved and what insiders, members of Congress and funds reported. Figures from filings and closing prices; none of this is a view on either stock.
- Market value
- $181B
- Last close
- $104.48
- 12 months
- −19.6%
- Market value
- $60.5B
- Last close
- $105.23
- 12 months
- +25.2%
At a glance
- By market value, Abbott Laboratories ($181.0B) is about 3.0 times Edwards Lifesciences ($60.5B).
- Over the last 12 months Abbott Laboratories's share price moved −19.6% and Edwards Lifesciences's +25.2%; against the S&P 500 that is −30.3 points and +14.6 points.
- In their last fiscal years Abbott Laboratories kept 14.7% of revenue as net income and Edwards Lifesciences 17.7%.
- In the last 90 days insiders reported 0 open-market purchases at Abbott Laboratories and 0 at Edwards Lifesciences; members of Congress disclosed 3 trades in Abbott Laboratories and 0 in Edwards Lifesciences.
- Next results: Abbott Laboratories Jan 20, 2027, Edwards Lifesciences Feb 8, 2027.
Share price over the last 12 months
Face to face
The figures that separate the two, drawn to the same scale. Every figure is also in the table below.
Size
Market value
Revenue, last fiscal year
Net income, last fiscal year
Every figure
| Abbott Laboratories ABTNYSE · Health Care Equipment | Edwards Lifesciences EWNYSE · Health Care Equipment | |
|---|---|---|
| Size and profitability | ||
| Market value | $181B | $60.5B |
| Revenue, last fiscal year | $44.3B | $6.07B |
| Net income, last fiscal year | $6.52B | $1.07B |
| Net marginNet income as a share of revenue | 14.7% | 17.7% |
| Free cash flow | $7.39B | |
Prices are end-of-day closes, and fundamentals are the companies' last annual figures from their SEC filings: a − or + in the table is a fact of the filing or the close, not a forecast. Market value is the company-level figure at the last close. Counts are of records OQRO holds, by their date; insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned sales under a 10b5-1 plan are counted like other sales.
Compare with another company
Abbott Laboratories against
Common questions
How is Abbott Laboratories different from Edwards Lifesciences?
Abbott Laboratories (ABT) is in Health Care Equipment on NYSE, with $44.3B of revenue in its last fiscal year and a net margin of 14.7%. Edwards Lifesciences (EW) is in Health Care Equipment on NYSE, with $6.07B of revenue in its last fiscal year and a net margin of 17.7%. Both are in the same industry, so the gap is mostly one of size and profitability. The table above sets their figures side by side; it compares filings and is not a view on either stock.
How do Abbott Laboratories and Edwards Lifesciences compare in size?
Abbott Laboratories has the larger market value: Abbott Laboratories $181B and Edwards Lifesciences $60.5B, at the last close.
Whose share price rose more over the last 12 months, ABT or EW?
Over the last 12 months Abbott Laboratories moved −19.6% and Edwards Lifesciences +25.2%. Past price moves say nothing about the future.
Which has had more insider buying, Abbott Laboratories or Edwards Lifesciences?
Since 2006, Abbott Laboratories insiders reported 377 open-market purchases against 12 for Edwards Lifesciences. These are counts of what was filed, not a view on either stock.
Do members of Congress trade ABT or EW?
In the last 12 months, members of Congress disclosed 28 trades in Abbott Laboratories (ABT) and 2 in Edwards Lifesciences (EW).
When did insiders last buy ABT and EW?
See the record behind any of these
A free account opens the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.
Abbott Laboratories pageEdwards Lifesciences pageRare insider trades this weekAll comparisons
https://oqro.io/compare/abt-vs-ew







